Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20061801 | 0.86 | CYP17A1 (0.38) | KDM4EPOLBHTTRAD52CLK1 | |
| SCHEMBL20061813 | 0.84 | CYP2A6 (0.31) | CLK1CYP2A6 | |
| SCHEMBL20061825 | 0.84 | MEN1 (0.34) | KDM4ECYP3A4ALDH1A1PKMHPGD | |
| SCHEMBL20061820 | 0.82 | EGFR (0.30) | — | |
| SCHEMBL20061785 | 0.82 | L3MBTL1 (0.38) | KDM4EPOLBHTTRAD52CYP2A6 | |
| SCHEMBL20061810 | 0.80 | KDM4E (0.33) | KDM4EPOLBHTTRAD52ALDH1A1 | |
| SCHEMBL20061804 | 0.78 | EGFR (0.35) | KDM4E | |
| SCHEMBL20061802 | 0.76 | NPC1 (0.30) | NPC1ALDH1A1 | |
| SCHEMBL20061798 | 0.75 | APAF1 (0.32) | HTTALDH1A1HPGD | |
| SCHEMBL20061790 | 0.73 | PDPK1 (0.35) | KDM4EPOLBHTTRAD52CLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11239432-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| US-20180108848-A1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180108848-A1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11239432-B2 | Organic electroluminescent materials and devices | OCIAD1, OSBP, OCIAD2 | KDM4E 4450/4885POLB 2476/4885HTT 4366/4885 |
| US-20180108848-A1 | Organic electroluminescent materials and devices | OSBP, OSBP2, OCIAD2 | KDM4E 4668/4885POLB 1972/4885HTT 3968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.